Currently, there are unanswered questions concerning survival advantage including those related to the underlying breast cancer subtype and prognostic criteria related to the index cancer; (eg. BRCA1 mutation carriers have the tendency to develop triple negative breast cancers) [11]. Here, BRCA1 is linked to breast carcinoma.